Related Experiment Video

Updated: Jul 17, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Aminoglycoside-induced ototoxicity

Erol Selimoglu1

  • 1Inonu University, Department of Otorhinolaryngology, Malatya, Turkey. erolselimoglu@hotmail.com

Current Pharmaceutical Design
|February 3, 2007
PubMed

Insights

Aminoglycoside antibiotics can cause irreversible ototoxicity, leading to hearing loss and vestibular dysfunction. Research explores genetic predispositions and anti-free radical agents for prevention.

Area of Science:

  • Ototoxicology
  • Pharmacology
  • Genetics

Background:

  • Aminoglycosides are crucial antibiotics with known irreversible ototoxicity.
  • Ototoxicity manifests as cochlear damage (hearing loss) or vestibulotoxicity (dizziness, ataxia).
  • Free radical generation in the inner ear is a proposed mechanism for aminoglycoside-induced ototoxicity.

Purpose of the Study:

  • To review the incidence, predisposition, mechanism, and prevention of aminoglycoside-induced ototoxicity.
  • To highlight the significance of aminoglycosides in treating infections and Meniere's disease.
  • To discuss strategies for mitigating aminoglycoside ototoxicity.

Main Methods:

  • Literature review of existing data on aminoglycoside ototoxicity.
  • Analysis of mechanisms, including free radical generation and genetic factors.
  • Evaluation of preventive strategies, such as anti-free radical agents.

Main Results:

  • Specific aminoglycosides exhibit differential toxicity (e.g., streptomycin/gentamicin vs. amikacin/kanamycin).
  • Mitochondrial 12S ribosomal RNA gene mutations are linked to increased susceptibility.
  • Anti-free radical agents, like salicylate, show potential in attenuating ototoxicity.

Conclusions:

  • Aminoglycoside ototoxicity is a significant concern requiring effective prevention strategies.
  • Understanding genetic predisposition and mechanisms is key to developing targeted interventions.
  • Further research into preventive measures is essential given the clinical importance of aminoglycosides.

More Related Videos

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...